Applying Lessons Learned from Nanomedicines to Understand Rare Hypersensitivity Reactions to mRNA-Based SARS-CoV-2 Vaccines

The authors share lessons learned over a decade of nanomedicine research and discuss the current knowledge about several factors that individually or collectively contribute to infusion reactions to nanomedicines.